At Northgate Technologies, Inc. (NTI) we are minimally invasive surgical product innovators. We’re passionate about making the surgical environment better for physicians and patients with products and services that improve minimally invasive procedures. We’re committed to continuous improvement, creativity and growth. Listed in Crain’s Chicago Business as one of the most innovative companies in 2013. NTI started as a R&D company in 1984, currently our lithotripsy technology is being used in more than 15 countries. NTI has OEM and/or distribution partnerships and over 77 issued and pending patents. NTI delivers value through high quality affordable, convenient, safe and easy-to-use surgical solutions for urology, gastroenterology, laparoscopy and endoscopy medical specialties.
Northgate’s culture is based on an organized, purposeful, and curious systematic analysis of opportunities and needs related to the improvement of medicine for both the physician and the patient. Since its inception, Northgate Technologies, Inc. has been a pioneer in the minimally invasive surgical market, beginning with its first patent for a revolutionary first to market high flow insufflator product and lithotripsy stone fragmentation. Today, our product portfolio consists of over 31 products and accessories. Our success in the market is a result of our reputation for producing quality products that get results for physicians and patients—improved safety, faster procedures, fewer complications and lower costs.
Our core team of innovators includes experienced medical industry professionals and specialists. When developing new products, we listen to the needs of our physicians, patients and customers to provide solutions to real-world challenges.
With our state-of-the-art production facility, NTI can bring new products and services to the market—fast. The company has had a number of groundbreaking “firsts” in the urology and surgical fields, including the first dual output 40 lpm insufflator with warming and humidification, making the peritoneal environment better for both patients and surgeons.
More recent evolutionary products include a 50 liter insufflator and new generation biliary and urology lithotripter generators. With over 77 patents issued and pending applications, NTI is focused on future growth. The company is expanding its offerings, with the development of new technology and product concepts for use in fluid delivery, insufflation and lithotripsy.